The misuse of opioid medications has contributed to a significant national crisis affecting public health as well as patient morbidity and medical costs. After orthopaedic surgical procedures, patients may require prescription (Rx) opioid medication, which can fuel the opioid epidemic. Opioid Rx usage after anterior cruciate ligament reconstruction (ACLR) is not well characterized.
Purpose:
To determine baseline utilization of Rx opioids in patients undergoing ACLR and examine demographic, patient, and surgical factors associated with greater and prolonged postoperative opioid utilization.
Study Design:
Cohort study; Level of evidence, 3.
Methods:
Primary elective ACLRs were identified using Kaiser Permanente’s ACLR registry (2005-2015). We studied the association of perioperative risk factors on the number of dispensed opioid Rx in the early (0-90 days) and late (91-360 days) postoperative recovery periods using logistic regression.
Results:
Of 21,202 ACLRs, 25.5% used at least 1 opioid Rx in the 1-year preoperative period; 17.7% and 2.7% used ≥2 opioid Rx in the early and late recovery periods, respectively. Risk factors associated with greater opioid Rx in both the early and the late periods included the following: ≥2 preoperative opioid Rx, age ≥20 years, American Society of Anesthesiologists classification ≥3, other activity at the time of injury, chondroplasty, chronic pulmonary disease, and substance abuse. Risk factors associated with opioid Rx use during the early period only included the following: other race, acute injury, meniscal injury repair, multiligament injury, and dementia/psychosis. Risk factors associated with greater opioid Rx during the late period only included the following: 1 preoperative opioid Rx, female sex, body mass index ≥25 kg/m2, motor vehicle accident as the mechanism of injury, and hypertension.
Conclusion:
A quarter of ACLR patients had at least 1 opioid Rx before the procedure, but usage dropped to 2.7% toward the end of the postoperative year. We identified several perioperative risk factors for greater and prolonged opioid usage after ACLR.
AbrechtCRCorneliusMWuAet al. Prediction of pain and opioid utilization in the perioperative period in patients undergoing primary knee arthroplasty: psychophysical and psychosocial factors. Pain Med. 2019;20(1):161-171.
AnthonyCAWestermannRWBedardNet al. Opioid demand before and after anterior cruciate ligament reconstruction. Am J Sports Med. 2017;45(13):3098-3103.
4.
BartelsKMayesLMDingmannCBullardKJHopferCJBinswangerIA.Opioid use and storage patterns by patients after hospital discharge following surgery. PLoS One. 2016;11(1):e0147972.
BedardNAPugelyAJWestermannRWDuchmanKRGlassNACallaghanJJ.Opioid use after total knee arthroplasty: trends and risk factors for prolonged use. J Arthroplasty. 2017;32(8):2390-2394.
7.
BicketMCLongJJPronovostPJAlexanderGCWuCL.Prescription opioid analgesics commonly unused after surgery: a systematic review. JAMA Surg. 2017;152(11):1066-1071.
8.
BrummettCMJandaAMSchuellerCMet al. Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty: a prospective, observational cohort study. Anesthesiology. 2013;119(6):1434-1443.
9.
BrummettCMWaljeeJFGoeslingJet al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504.
CepedaMSCarrDB.Women experience more pain and require more morphine than men to achieve a similar degree of analgesia. Anesth Analg. 2003;97(5):1464-1468.
14.
CheahJWSingDCMcLaughlinDFeeleyBTMaCBZhangAL.The perioperative effects of chronic preoperative opioid use on shoulder arthroplasty outcomes. J Shoulder Elbow Surg. 2017;26(11):1908-1914.
15.
ChooEKDouriezCGreenT.Gender and prescription opioid misuse in the emergency department. Acad Emerg Med. 2014;21(12):1493-1498.
16.
DowellDHaegerichTMChouR.CDC guideline for prescribing opioids for chronic pain: United States, 2016. MMWR Recomm Rep. 2016;65(1):1-49.
17.
ElixhauserASteinerCHarrisDRCoffeyRM.Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.
18.
GoeslingJMoserSEZaidiBet al. Trends and predictors of opioid use after total knee and total hip arthroplasty. Pain. 2016;157(6):1259-1265.
19.
GostinLOHodgeJGJrNoeSA.Reframing the opioid epidemic as a national emergency. JAMA. 2017;318(16):1539-1540.
20.
GrodofskySRSinhaAC.The association of gender and body mass index with postoperative pain scores when undergoing ankle fracture surgery. J Anaesthesiol Clin Pharmacol. 2014;30(2):248-252.
21.
GuyGPJrZhangKBohmMKet al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(26):697-704.
22.
HadlandsmythKVander WegMWMcCoyKDMosherHJVaughan-SarrazinMSLundBC.Risk for prolonged opioid use following total knee arthroplasty in veterans. J Arthroplasty. 2018;33(1):119-123.
23.
HansenRNOsterGEdelsbergJWoodyGESullivanSD.Economic costs of nonmedical use of prescription opioids. Clin J Pain. 2011;27(3):194-202.
HittHCMcMillenRCThornton-NeavesTKochKCosbyAG.Comorbidity of obesity and pain in a general population: results from the Southern Pain Prevalence Study. J Pain. 2007;8(5):430-436.
JohnstonLDMiechRAO’MalleyPMBachmanJGSchulenberJEPatrickME.Monitoring the Future national survey results on drug use: 1975-2017. Overview, key findings on adolescent drug use. Available at: http://www.monitoringthefuture.org/pubs/monographs/mtf-overview2017.pdf. Accessed September 4, 2018.
KayeADJonesMRKayeAMet al. Prescription opioid abuse in chronic pain. An updated review of opioid abuse predictors and strategies to curb opioid abuse: part 1. Pain Physician. 2017;20(2S):S93-S109.
30.
KayeADJonesMRKayeAMet al. Prescription opioid abuse in chronic pain. An updated review of opioid abuse predictors and strategies to curb opioid abuse: part 2. Pain Physician. 2017;20(2S):S111-S133.
31.
KimSCChoudhryNFranklinJMet al. Patterns and predictors of persistent opioid use following hip or knee arthroplasty. Osteoarthritis Cartilage. 2017;25(9):1399-1406.
32.
KoonsALRayl GreenbergMCannonRDBeauchampGA.Women and the experience of pain and opioid use disorder: a literature-based commentary. Clin Ther. 2018;40(2):190-196.
33.
LeeCWHoIK.Sex differences in opioid analgesia and addiction: interactions among opioid receptors and estrogen receptors. Mol Pain. 2013;9:45.
34.
MacdonaldSAHeardSMHiemstraLABuchkoGMKerslakeSSasyniukTM.A comparison of pain scores and medication use in patients undergoing single-bundle or double-bundle anterior cruciate ligament reconstruction. Can J Surg. 2014;57(3):E98-E104.
35.
MaletisGBInacioMCFunahashiTT.Analysis of 16,192 anterior cruciate ligament reconstructions from a community-based registry. Am J Sports Med. 2013;41(9):2090-2098.
36.
MatijevicMUzarevicZGvozdicVet al. Does body mass index and position of impacted lower third molar affect the postoperative pain intensity?Coll Antropol. 2012;36(4):1279-1285.
37.
MiechRJohnstonLO’MalleyPMKeyesKMHeardK.Prescription opioids in adolescence and future opioid misuse. Pediatrics. 2015;136(5):e1169-e1177.
38.
MorrisBJLaughlinMSElkousyHAGartsmanGMEdwardsTB.Preoperative opioid use and outcomes after reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2015;24(1):11-16.
39.
MorrisBJSciasciaADJacobsCAEdwardsTB.Preoperative opioid use associated with worse outcomes after anatomic shoulder arthroplasty. J Shoulder Elbow Surg. 2016;25(4):619-623.
40.
NambaRSSinghAPaxtonEWInacioMCS. Patient factors associated with prolonged postoperative opioid use after total knee arthroplasty. J Arthroplasty. 2018;33(8):2449-2454.
41.
NarainASHijjiFYHawsBEet al. Impact of body mass index on surgical outcomes, narcotics consumption, and hospital costs following anterior cervical discectomy and fusion. J Neurosurg Spine. 2018;28(2):160-166.
42.
PaxtonEWKileyMLLoveRBarberTCFunahashiTTInacioMC.Kaiser Permanente implant registries benefit patient safety, quality improvement, cost-effectiveness. Jt Comm J Qual Patient Saf. 2013;39(6):246-252.
43.
QuanHSundararajanVHalfonPet al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139.
44.
RaebelMANewcomerSRReiflerLMet al. Chronic use of opioid medications before and after bariatric surgery. JAMA. 2013;310(13):1369-1376.
45.
RaoAGChanPHPrenticeHAet al. Risk factors for postoperative opioid use after elective shoulder arthroplasty. J Shoulder Elbow Surg. 2018;27(11):1960-1968.
46.
RubinDB.Multiple Imputation for Nonresponse in Surveys. New York: Wiley; 1987.
47.
RuddRASethPDavidFSchollL.Increases in drug and opioid-involved overdose deaths: United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445-1452.
48.
ScullyRESchoenfeldAJJiangWet al. Defining optimal length of opioid pain medication prescription after common surgical procedures. JAMA Surg. 2018;153(1):37-43.
49.
SinghJALewallenD.Predictors of pain and use of pain medications following primary total hip arthroplasty (THA): 5,707 THAs at 2-years and 3,289 THAs at 5-years. BMC Musculoskelet Disord. 2010;11:90.
50.
SinghJALewallenDG.Predictors of use of pain medications for persistent knee pain after primary total knee arthroplasty: a cohort study using an institutional joint registry. Arthritis Res Ther. 2012;14(6):R248.
51.
SmithSRBidoJCollinsJEYangHKatzJNLosinaE.Impact of preoperative opioid use on total knee arthroplasty outcomes. J Bone Joint Surg Am. 2017;99(10):803-808.
52.
SunECDarnallBDBakerLCMackeyS.Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med. 2016;176(9):1286-1293.
53.
van HelmondNTimmermanHvan DasselaarNTet al. High body mass index is a potential risk factor for persistent postoperative pain after breast cancer treatment. Pain Physician. 2017;20(5):E661-E671.
54.
WestermannRWAnthonyCABedardNet al. Opioid consumption after rotator cuff repair. Arthroscopy. 2017;33(8):1467-1472.
55.
WunschHWijeysunderaDNPassarellaMANeumanMD.Opioids prescribed after low-risk surgical procedures in the United States, 2004-2012. JAMA. 2016;315(15):1654-1657.
